1 Min Read
March 6 (Reuters) - TaiMed Biologics Inc:
* Says it got right of sale in Europe for its AIDS new drug TMB-355
Source text in Chinese: goo.gl/q2gQW6
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.